Brackley, Highland, United Kingdom Hygea VCT appeared to be the VC, which was created in 2001. The leading representative office of defined VC is situated in the Brackley. The fund was located in Europe if to be more exact in United Kingdom.
Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this Hygea VCT performs on 9 percentage points more the average number of lead investments. The top activity for fund was in 2010. The top amount of exits for fund were in 2010. The common things for fund are deals in the range of 1 - 5 millions dollars.
The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Purely Proteins Limited, ImmunoBiology Ltd, Scancell.
Besides them, we counted 1 critical employee of this fund in our database.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Hygea VCT, startups are often financed by Oxford Technology Management, Oxford Capital Partners, Entrepreneurs Fund. The meaningful sponsors for the fund in investment in the same round are Oxford Capital Partners, Oxford Technology Management, MTI. In the next rounds fund is usually obtained by Oxford Capital Partners, Parkwalk Advisors, MTI.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Eykona Medical | $1M | 24 Sep 2010 | Oxford, England, United Kingdom | ||
| $3M | 01 Dec 2004 | United Kingdom, England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Eykona Medical | $1M | 24 Sep 2010 | Oxford, England, United Kingdom | ||
| $3M | 01 Dec 2004 | United Kingdom, England |
